Cision PR Newswire

ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Nov. 21, 2023 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Piper Sandler 35th Annual Healthcare Conference on Thursday, November 30, 2023, at 12:00 p.m. ET in New York.

David. R. Parkinson, President, and Chief Executive Officer; Peter Virsik, Chief Operating Officer; and David S. Wood, Chief Financial Officer, will host and participate in one-on-one meetings.

A live webcast of the fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at Following the event, the webcast will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit, and follow us on Twitter and LinkedIn.


ESSA Pharma, Inc.
Peter Virsik, Chief Operating Officer

Investors and Media:
Argot Partners

Cision View original content:


NOTE: This content is not written by or endorsed by "WTWO/WAWV", its advertisers, or Nexstar Media Inc.

For inquiries or corrections to Press Releases, please reach out to Cision.